a public good project by the
Synthesis
Company
of California

© 2026

Acary Souza Bullé Oliveira | doi.page

0 works0 citations0 h-index

Acary Souza Bullé Oliveira

Universidade Federal de São Paulo(BR)

Publications by Year

Research Areas

Neurogenetic and Muscular Disorders Research, Amyotrophic Lateral Sclerosis Research, Muscle Physiology and Disorders, Genetic Neurodegenerative Diseases, Neurological diseases and metabolism

Most-Cited Works

→ Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study(2017)764 cited
→ Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients(2011)209 cited
→ Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks(2016)209 cited
→ Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial(2021)176 cited
→ Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes(2020)105 cited
→ Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population(1999)98 cited

→ Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever(2009)88 cited

→ Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension(2020)75 cited

→ Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021(2021)73 cited

Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence.(2004)